T he number of elderly patients with end-stage renal failure is rising disproportionately (1) and dialysis in these patients is challenging due to substantial comorbidity. As a result, USA registry data indicate a 2-year survival rate of 51.5% in dialysis patients aged 70 -79 years (2) . A considerable proportion of these patients suffer from cardiovascular disease and access problems (3, 4) to the extent that some fail hemodialysis (HD) entirely. In theory, many of these patients are good candidates for peritoneal dialysis (PD), not least because the need for a vascular access is obviated. Cardiovascular stability on PD is also excellent (5) . Unfortunately, many of these patients cannot perform PD at home. Accordingly, only 4.9% of all end-stage renal failure patients aged 70 -79 years in the United States were on PD in 2004 (2) .
Several approaches have been pursued to facilitate PD in these patients. The use of nightly automated PD with visits by nursing staff has been described elsewhere (6) , while others propose assisted PD in nursing homes (7) . To our knowledge, specific funding for assisted PD exists only in Belgium, France, one region of Spain, and in Denmark (8) . However, assisted PD is not covered by German health insurance, while in-center intermittent peritoneal dialysis (IPD) is (9) . Under these circumstances, IPD may represent the only treatment option for patients that have failed HD and home PD, and in whom palliative care alone seems inappropriate. Unfortunately, current data on selection of patients, complications, peritonitis, rates of hospitalization, and survival on IPD are not available and renal registries do not even list IPD as a distinct modality.
Intermittent PD has been performed in our unit since the 1990s; hence, we took the opportunity for a retrospective single-center study of patients that underwent IPD at Hannover Medical School, Germany, between 1997 and 2007.
searched the list of concomitant disorders to find evidence of musculoskeletal or visual impairment or neurological disease that may have precluded home therapy. It was also recorded whether training for home PD had ever been attempted; days in training were calculated from the computer database, as training mandates special reimbursement.
CLINICAL DATA, LABORATORY VALUES, AND INDEX OF COMORBIDITY
Serum potassium, creatinine, urea, phosphate, albumin, C-reactive protein (CRP), and hemoglobin values on the first day of IPD were obtained from our computer database. Height and predialysis weight were obtained from IPD protocols. The number of drugs in total and the number of antihypertensive drugs (excluding diuretics) were retrieved from discharge letters and quarterly letters to the general practitioners. Comorbidity was assessed using the Charlson Comorbidity Index (CCI) (10) . Levels of glycosylated hemoglobin (HbA1c) were obtained in patients with diabetes.
RATES OF HOSPITALIZATION, PERITONITIS, AND SURVIVAL
The number and duration of admissions and admission diagnoses were retrieved from the hospital database, discharge letters, our computer database, and the paper file. Admissions for PD catheter implantation were not counted. Episodes of peritonitis and noninfectious catheter problems were retrieved from our database. Episodes of exit-site infection were not counted because documentation was incomplete. The day of death was obtained from hospital files and from our database; presumed causes of death were retrieved from hospital letters and by interviewing the general practitioners.
STATISTICS
Paired t testing was used to compare body mass indices, laboratory values, and quality-of-life scores at baseline and after 3 months. Wilcoxon signed rank testing was used to compare numbers of drugs. Survival was characterized by Kaplan-Meier analysis. The influence of clinical variables, laboratory values, episodes of hospital admission, and length of stay on survival was tested with Cox regression analysis; the influence of sex and presence of diabetes or CHF on survival was evaluated with log rank testing. The null hypothesis was rejected at a two-tailed p < 0.05. The software was SPSS version 15 (SPSS Inc., Chicago, Illinois, USA).
METHODS

SETUP OF THE IPD UNIT AND IPD PRESCRIPTION
All patients were treated at the IPD unit at Hannover Medical School, Hannover, Germany. The unit is located within the outpatient dialysis building and staffed with nurses that have long-term experience in PD. Each patient underwent daytime sessions of 7.5 -8 hours with the Baxter HomeChoice cycler and Dianeal solutions (Baxter, Heidelberg, Germany) via Oreopoulos-Zellerman catheters. The length of the sessions was chosen for reasons of practicality alone, since there was no staffing of our IPD unit beyond the afternoon. Intermittent PD was typically started with 10-L or 15-L dialysate volumes per session, depending on weight and clinical impression of the patient's abdomen, and increased to up to 20 L if tolerated. We also measured weekly PD clearance (L/week/1.73 m 2 ) in our current IPD cohort (n = 5). This was done long after those patients had started IPD (i.e., at least 3 months). However, we were not able to determine residual renal function, particularly because comorbidity, age, and incontinence did not permit 24-hour urine sampling in these patients. Table 1 provides the dialysis prescriptions of all patients as well as weekly PD clearances in our current IPD cohort (n = 5).
IDENTIFICATION OF PATIENTS
We were able to identify patients that received IPD for more than 4 weeks between 1 March 1997 and 1 March 2007 by a search of the computer database because all episodes of IPD are coded for reimbursement.
RETRIEVAL OF CLINICAL DATA
Clinical data were obtained from our computer database and from comprehensive quarterly letters to the general practitioners -the latter are a prerequisite for reimbursement in Germany. The hospital database provided discharge letters, medication, laboratory values, and dialysis protocols. Reasons for choosing IPD were gleaned from discharge letters. Ejection fractions were retrieved from echocardiography and cardiac catheterization reports in patients that received IPD because of congestive heart failure (CHF). The number of interventions to create or salvage an arteriovenous fistula was also noted. Surgical files were retrieved to identify patients that received their PD catheter under local anesthetic. We interviewed our PD nurses to record whether refusal of home therapy had played a role and we 
RESULTS
The search of our computerized files identif ied 30 patients that received IPD between 1 March 1997 and 1 March 2007. All patients that underwent IPD at our institution during that time were included. Mean age on the first day of IPD was 73.4 (range 58 -92) years. The underlying renal disorder was biopsy-proven in 6 patients (20%). The leading cause of renal failure was hypertensive/vascular nephropathy (n = 12, 40%), followed by diabetic nephropathy (n = 6, 20%). Table 2 provides underlying renal disorders. Among the reasons for choosing IPD, CHF was most common (n = 15; 50% of patients), with a mean ejection fraction of 35%, followed by refusal of home therapy (n = 12; 40%) by relatives (n = 8) and patients (n = 4). Recurrent access problems (n = 7; 23.3%), with an average of 2.3 interventions per patient, and patient preference (n = 7; 23.3%) were also common. One patient had heparin-induced thrombocytopenia and 1 had thrombophilia. Only 1 patient had performed continuous ambulatory PD (CAPD) previously and became unable to do so after stroke. Two of 4 patients that had initially refused home therapy graduated to home PD after some time on IPD. Seventeen patients (56.6%) had received HD in hospital prior to PD catheter surgery. Of these patients, 6 had a failed access, 1 had subclavian vein thrombosis, and 1 had chest wall hematoma after two attempts to insert a catheter. Median CCI score of our patients was 6 (n = 30). Congestive heart failure was the most common concomitant disease (n = 23; 76.7%), followed by ischemic heart disease (n = 14; 46.6%). Six patients (20%) were in atrial fibrillation, 3 patients (10%) had an automated implanted cardioverter defibrillator, 3 had a pacemaker, and 3 patients had been resuscitated previously. Three patients underwent PD catheter surgery under local anesthetic. Nine patients (30%) had peripheral vascular disease. Mean number of concomitant diseases, excluding renal failure, was 12.7 per patient (range 7 -23). Thirteen patients (43.3%) had diabetes mellitus and 8 of them were insulin dependent. At baseline, 8 patients (26.7%) lived alone and 3 (10%) were in nursing homes. Twelve patients (40%) had disorders that impaired mobility (e.g., osteoarthritis), 20 (66.7%) had diseases of the central nervous system, and 3 (10%) had both. Three patients (10%) had visual impairment. Twenty-two patients (73.3%) had at least one disorder that hampered home PD. Table 3 provides age, sex, underlying renal diseases, reasons for choosing IPD, and important concomitant disorders.
Ten patients (33.3%) underwent training; mean duration of training was 18.6 (10 -39) days: 3 patients failed and 7 graduated to home PD. Five of these 7 patients died after a median of 4 months on home PD (range 1 -6 months), 1 patient is alive after 48 months of home PD, and 1 patient spent 26 months on home PD and then returned to IPD. Training was never attempted in 20 patients (66.6%).
There were 51 hospital admissions while on IPD (mean 1.7 admissions/patient, range 0 -6), equaling 1.39 admissions per IPD-year. Mean length of stay was 25.7 days per patient and 1.75 days per IPD-month. Seven patients (23.3%) had no admissions. The leading reasons for admission (Table 4) were cardiac disease (n = 9; 17.6%) and peritonitis (n = 9; 17.6%), followed by peripheral vascular disease (8 episodes; 15.2%). There was 1 episode of peritonitis every 48.8 IPD-months. Of the 9 episodes of peritonitis, 2 were due to Staphylococcus aureus (22.2%), 1 to S. epidermidis (11.1%), 2 to Enterococcus spp, and 2 to gram-negative organisms; no growth was observed in 2 episodes. Noninfectious catheter problems were rare (n = 5). Leakage, displacement of the PD catheter, and inguinal hernia, which occurred in 1 case each, were managed conservatively. One patient had abdominal hematoma necessitating surgical revision and 1 sustained pleural leakage that prompted a change to HD.
Laboratory values showed a significant decline in serum urea after 3 months compared with baseline (p = 0.004), while serum hemoglobin increased significantly (p < 0.001). The number of drugs increased significantly after 3 months (p = 0.002). Body mass indices, number of antihypertensive drugs, and all other laboratory values showed no significant change (Table 5 ). Mean HbA1c in the diabetic patients was 6.8% at baseline (n = 13) and 6.3% after 3 months of IPD (n = 12). One patient acquired diabetes subsequent to the start of IPD treatment. When interpreting the laboratory values, it has to be appreciated that 17 patients (56.7%) were on HD before IPD; however, there was no statistical difference in baseline serum creatinine, serum urea, or serum phosphate between patients with and patients without previous HD (data not shown). Median glomerular filtration rate, estimated by the four-variable Modification of Diet in Renal Disease (MDRD) formula, prior to the start of IPD was 10 mL/minute (compared to 10 mL/minute in those without a previous attempt of HD, n = 13).
In total, 439 patient-months on IPD were completed (mean 14.6 months, median 7 months, range 1 -61 months). Two patients changed to HD and 7 patients (23.3%) learned CAPD; 2 patients stopped dialysis due to recovery of renal function. Fourteen patients (46.7%) died on IPD, 5 died on CAPD, 2 died on HD, and 1 died off dialysis with sufficient renal function. As of March 2007, 8 patients (26.7%) were alive (6 on IPD, 1 on CAPD, and 1 with sufficient renal function off dialysis); 22 patients (73.3%) had died. Kaplan-Meier analysis (Figure 1 ) revealed a mean survival of 26.6 months (95% confidence interval 16.4 -36.8 months) with a median of 17 months (95% confidence interval 9.7 -24.3 months) and a range of 1 -80 months (n = 30). Leading causes of death (n = 22) were sepsis (n = 13; 59.1% of deaths) and cardiac disease (n = 7; 31.8%); 4 patients with sepsis had peritonitis, 3 had pneumonia, and 2 had peripheral vascular disease. One patient died from gastrointestinal hemorrhage and 1 from intracranial hematoma. A similar distribution was observed in patients that died on IPD (n = 14; sepsis n = 9, 64.3%; cardiac disease n = 5, 35.7%).
Cox regression analysis showed a significant influence of CRP levels on survival after 3 months (p = 0.005, hazard ratio = 1.118). All other laboratory values, total number of drugs, number of antihypertensive drugs, body mass indices at baseline and 3 months, age, and episodes and days of hospitalization showed no significant influence on survival. Finally, log rank testing showed a nonsignificant tendency for worse survival in males (p = 0.058), while there was no difference between diabetics and nondiabetics (p = 0.92), or between patients with and patients without CHF (p = 0.70).
DISCUSSION
Renal replacement therapy in an ever-expanding population of elderly and/or multimorbid patients with end-stage renal failure is a difficult task. A proportion of these patients could do well on PD (11, 12) ; successful PD has been reported in octo-and nonagenarians (13, 14) . Unfortunately, many of them cannot perform PD themselves (11) . In-center IPD is sometimes performed in such patients, although it is often considered inappropriate since complications, frequency of admission to hospital, and survival are believed to be catastrophic. These assumptions are not based on any current data and both the USRDS (2) and its UK equivalent (15) lack specific data on IPD. The German registry stopped recording IPD data in 1999 (Haas K, personal communication). Our study represents a single center's experience with 439 months of IPD in 30 consecutive patients and provides valuable data.
Due to access problems, cardiovascular instability, or both, 56.6% of our patients failed a trial of HD. Our clinical data delineate a strong rationale for PD since 76.7% of our patients had CHF (16) . The fact that 10% of our patients had a previous episode of resuscitation, an automated implanted cardioverter defibrillator device, or implantation of the PD catheter under local anesthetic (because it was felt they could not survive general anesthesia) provides further evidence that our patients were desperately ill. One of our patients had thrombophilia and 23.3% of our patients had recurrent vascular access Failed AV fistula twice; relatives COPD, liver cirrhosis refused home PD PD = peritoneal dialysis; CHF = congestive heart failure; HIT = heparin-induced thrombocytopenia; CAPD = continuous ambulatory PD; AV = arteriovenous; IHD = ischemic heart disease; CABG = coronary artery bypass grafting; PVD = peripheral vascular disease; COPD = chronic obstructive pulmonary disease; MI = myocardial infarction; NYHA = New York Heart Association; PIP = proximal interphalangeal joint; AICD = automated implanted cardioverter defibrillator. problems, two other well-established reasons to choose PD (17) . Finally, patients often preferred PD and such preference has been described previously (18) . We were particularly interested in understanding the reasons why home PD failed in these patients. Elderly patients with poor social support are particularly likely to fail home PD and more than one third of our patients lived alone or in nursing homes. Refusal of home therapy occurred in as many as 40% and predominantly by relatives; significant burden and adverse effects on the quality of life of relatives of elderly PD patients have been reported previously (19) . We emphasize that predialysis counseling in this population must include a comprehensive assessment of the relatives. Musculoskeletal disease, visual impairment, and disorders of the central nervous system hampered home therapy in as many as 73.3% of our patients. Ultraviolet light chambers have been advocated in patients with impaired dexterity or vision but their use has declined. Dialysis instructions on audiotape have been used for patients with impaired memory (20) . Novel approaches in these patients are eagerly awaited.
Assisted PD at home with help from dedicated nurses (21) has been described in patients that cannot perform PD themselves. However, to our knowledge, specific funding for assisted PD exists only in Belgium, France, one region of Spain, and in Denmark (8) . However, this modality is not available in Germany due to lack of funding and our own attempts to establish PD in nursing homes (7) have failed.
We were surprised to see that 23.3% of our patients eventually graduated to home PD. The fact that 1 patient needed 39 days for successful training underscores the need for patience in such attempts. We speculate that cognitive abilities and motivation improved with correction of uremia. Dialysis could be stopped in 2 patients that recovered from a vicious circle of CHF and acute-onchronic renal failure and we have described one of them elsewhere (22) .
Contrary to a widely held belief, rates of hospitalization in this severely ill cohort of IPD patients were acceptable, not least because we tried to avoid admissions if at all possible. Our patients spent 1.75 days per IPDmonth in hospital and 7 patients had no admissions whatsoever. Our data of 1.39 admissions per IPD-year compare favorably with the literature: The North Thames Dialysis Study previously described hospitalization rates in the region of 2 admissions per patient-year in elderly dialysis patients (23).
Peritonitis was rare, presumably due to excellent nursing care, and gram-positive organisms were less common than usually seen in patients on home PD (24) . However, peritonitis represented one of the two leading causes of admission and the cause of death on IPD in as many as 4 patients. Our impression is that exit-site infections are equally uncommon, although we were unable to enumerate such events. Not surprisingly, cardiac disease was the other leading cause for admission but we were surprised to see that peripheral vascular disease was the next most common cause; hence, we emphasize the need for regular foot care.
It is often claimed that survival on IPD is dismal and that long-term survival does not exist. Of our 30 patients, 22 had died up to 1 March 2007; 14 patients died while on IPD. Kaplan-Meier analysis revealed mean survival of 26.6 ± 5.2 months, with a much lower median of 17 ± 3.73 months. This right-skewed distribution suggests that many patients die early on, while some experience long-term survival. The comorbidity in our cohort is underscored by a mean of more than 12 concomitant diagnoses per patient; the CCI was 6 (10). Three-year patient survival in our cohort was 30% (Figure 1) . A report from the French PD Registry demonstrated a 3-year patient survival between 30% (diabetics) and 42% (nondiabetics) in patients aged 70 -80 years. Three-year survival in PD patients with a CCI above 6 was 29.6 in that study (25) . Mean serum albumin was 3.33 g/L after 3 months, with low-normal body mass indices, suggesting that some degree of malnutrition was present, as described previously in elderly PD patients (11) . Evidence of inflammation was also present, with elevated CRP values at baseline and after 3 months. Inflammation and malnutrition indicate an unfavorable prognosis (26) . Fried and co-workers reported a mortality rate in the range of 22/100 dialysis-years for PD patients with a CCI score of 6 (27) . However, the CCI score does not reflect the functional status of patients, which was poor in most of our patients. Finally, our survival data must be gauged against the fact that, for most patients, there was no alternative: they had either failed HD or HD had been considered impossible. Furthermore, they had failed or refused home PD training. Assisted PD was not available; hence, IPD represented the only option apart from palliative care alone. Under these circumstances, survival was better than we had expected. In fact, 26.7% of the patients from this cohort are still alive at time of writing.
Intermittent PD has disadvantages and time spent on dialysis is of particular concern. Another concern is adequacy of dialysis and subclinical uremia between dialysis sessions. In addition, IPD is only suitable for patients with reasonable urine output. We measured weekly peritoneal clearances in our current IPD cohort. Not surprisingly, these values did not match any of the current PD guidelines. Dedicated guidelines for adequacy of IPD do not exist and this issue may warrant future consideration. Nightly in-center IPD with longer duration of sessions may achieve higher weekly clearances. Our study demonstrates reasonable laboratory values after 3 months and we found no clinical signs of uremia. Serum urea declined significantly compared to baseline, while laboratory values at baseline were not very revealing, presumably because most patients had received prior in-hospital HD. Thus, although our weekly clearances were low, they may just be sufficient only for an elderly patient with good residual renal function and diuresis, low muscle mass, and diminished dietary intake. Others have previously highlighted the inability of peritoneal small solute clearances to predict outcomes (28, 29) .
Ethical issues must be appreciated as well (30) and it is not our intention to advocate dialysis in every patient. Decisions to dialyze or not remain notoriously difficult (22) and such discussions are further hampered by late referral (31) . A decision to proceed with IPD does not exclude advance care planning (32) and 5 of 6 patients in our current IPD population have Do Not Resuscitate orders. Along the same line, we are prepared to stop IPD if a patient deteriorates rapidly and after discussion with patient and relatives.
There are several obvious limitations to our retrospective study. In our search for reasons that precluded home therapy, we relied on notes and nurses' memory, which leaves room for error although our dedicated PD nurses knew all these patients well. Our study also lacked data on residual renal function because our patients were unable to collect 24-hour urines. However, the median estimated glomerular filtration rate prior to the start of IPD was 10 mL/minute. The fact that there was no difference in the estimated glomerular filtration rate between dialysis-naïve patients and those with a previous attempt of HD underscores that the latter group did not receive adequate dialysis due to intractable access problems, hemodynamic instability, or both. We measured weekly PD clearances only in our current IPD cohort, although this should provide an idea regarding the dimensions of clearances in our cohort. Weekly clearances, membrane characteristics, and nutrition data were not routinely obtained because it was felt that results would not alter management. Our inability to enumerate exitsite infections was another limitation.
In summary, our study suggests that rates of peritonitis, hospitalization, and survival on IPD are not as catastrophic as is often claimed. We do not envision IPD as a large-scale treatment but we regard it as a niche modality for patients without alternatives, that is, for patients that have failed both HD and training for home PD. Suitable patients in whom palliative care alone is felt to be inappropriate should not be denied a trial of IPD if they so choose and after every attempt to establish home or assisted PD has been exhausted. Intermittent PD is in some way a palliative treatment and may be viewed as yet another option within the spectrum of end-of-life care in nephrology. Registries should contain data on IPD and prospective studies should focus on quality of life on and cost of IPD.
